SCHEMBL23286926

SCHEMBL23286926

CNc1ccc(C(=O)OC)cc1NCCOC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGER4 P35408 4/20 0.56
▸ ALDH1A1 P00352 7/20 0.52
▸ MAPT P10636 5/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ HCAR3 P49019 2/20 0.50
▸ KDM4E B2RXH2 6/20 0.46
▸ HSD17B10 Q99714 3/20 0.46
▸ GAA P10253 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ HPGD P15428 4/20 0.43
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA7 P43166 1/20 0.42
▸ XDH P47989 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ CA14 Q9ULX7 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ MAPK14 Q16539 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23287173 0.88 PTGER4 (0.70) PTGER4ALDH1A1MAPTRAB9AHCAR3
SCHEMBL23490760 0.88 PTGER4 (0.51) PTGER4ALDH1A1MAPTRAB9AHCAR3
SCHEMBL25933702 0.84 PTGER4 (0.61) PTGER4ALDH1A1MAPTRAB9AHCAR3
SCHEMBL2249029 0.82 PTGER4 (0.80) PTGER4ALDH1A1MAPTRAB9AHCAR3
SCHEMBL20266373 0.82 PTGER4 (0.64) PTGER4ALDH1A1MAPTRAB9AHCAR3
SCHEMBL29825520 0.82 PTGER4 (0.80) PTGER4ALDH1A1MAPTRAB9AHCAR3
SCHEMBL25314456 0.82 PTGER4 (0.56) PTGER4ALDH1A1MAPTRAB9AHCAR3
SCHEMBL30230127 0.80 PTGER4 (0.51) PTGER4ALDH1A1MAPTRAB9AHCAR3
SCHEMBL24214196 0.79 PTGER4 (0.53) PTGER4ALDH1A1MAPTRAB9AHCAR3
SCHEMBL26987784 0.79 PTGER4 (0.53) PTGER4ALDH1A1MAPTRAB9AHCAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702404-B2 GLP-1R modulating compounds GILEAD SCIENCES, INC. (US) 2023-07-18 — — US disclosed
US-20210171499-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2021-06-10 — — US disclosed
WO-2021081207-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2021-04-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702404-B2 GLP-1R modulating compounds GLP1R, GIPR, GPR119 PTGER4 996/4885ALDH1A1 3556/4885MAPT 3314/4885
US-20210171499-A1 GLP-1R MODULATING COMPOUNDS GLP1R, GIPR, GPR119 PTGER4 996/4885ALDH1A1 3556/4885MAPT 3314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback